New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
10:47 EDTIRWDIronwood, Almirall say Constella approved in Europe for treatment of IBS-C
Almirall and Ironwood Pharmaceuticals announced that the European Commission has granted marketing authorization to Constella for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation, or IBS-C, in adults. This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use in September.
News For IRWD From The Last 14 Days
Check below for free stories on IRWD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
10:32 EDTIRWDHigh option volume stocks
High option volume stocks: BXR IRWD ACM CECO TCK JAH MNST AVB EDU DAR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use